Description
Aflatoxin Q1 is a hydroxy metabolite of the mycotoxin aflatoxin B1. Human CYP3A4 study suggests aflatoxin Q1 is a detoxification product that is no longer mutagenic.
| Product Unit Size | Cost | Quantity | Stock |
|---|
Aflatoxin Q1 is a hydroxy metabolite of the mycotoxin aflatoxin B1. Human CYP3A4 study suggests aflatoxin Q1 is a detoxification product that is no longer mutagenic.
| Cas No. | 52819-96-2 |
|---|---|
| Purity | ≥98% |
| Formula | C17H12O7 |
| Formula Wt. | 328.27 |
| Chemical Name | (3S,6aR,9aS)-3-hydroxy-4-methoxy-2,3-dihydrocyclopenta[c]furo[3',2':4,5]furo[2,3-h]chromene-1,11(6aH,9aH)-dione |
| IUPAC Name | (3S,6aR,9aS)-3-Hydroxy-4-methoxy-2,3,6a,9a-tetrahydrocyclopenta[c]furo[3',2':4,5]furo[2,3-h]chromene-1,11-dione |
| Synonym | AFQ1 |
| Appearance | Off white powder |
| Store Temp | 4°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Yourtee DM, Bean TA, Kirk-Yourtee CL. Human aflatoxin B1 metabolism: an investigation of the importance of aflatoxin Q1 as a metabolite of hepatic post-mitochondrial fraction. Toxicol Lett. 198738(3):213-24. doi: 10.1016/0378-4274(87)90002-6, PMID: 3116726
M. Yamada , K. Hatsuta , M Niikawa, et al. Detoxification of Aflatoxin B1 Contaminated Maize Using Human CYP3A4 J. Microbiol Biotechnol 2020, 28;30(8):1207-1213. doi: 10.4014/jmb.2003.03032 PMID: 32423188
NS3/4A inhibitor
NSAID; COX-2 inhibitor.
4-Hydroxytamoxifen prodrug; FIASMA, SERM, PKC i...
Synthetic cytokinin, plant growth regulator; fi...
Enone.
PKA inhibitor, potential ROCK, S6K1, MSK1, PKB ...
Reduces production of thyroid hormones
Iron chelator.
Iridoid glycoside found in Gardenia.
Endogenous sterol component of animal cell memb...
Mycotoxin contaminant found in cereal grains.
Fermentation impurity
Benzimidazole; microtubule polymerization inhib...
Endogenous tripeptide, involved in HPA signalin...
Arp2/3 inhibitor.
α4β2 nAChR desensitizer, delayed-rectifier vo...
L-type and T-type Ca2+ and TRP antagonist.
Nucleoside (thymidine) analog; DNA chain termin...
FIASMA, L-type Ca2+ channel blocker, D2 antagon...
AurKA inhibitor.